Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014464
Filing Date
2022-08-04
Accepted
2022-08-04 07:10:44
Documents
84
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-20220630.htm   iXBRL 10-Q 3905949
2 EX-10.1 ortx-ex10_1.htm EX-10.1 892790
3 EX-31.1 ortx-ex31_1.htm EX-31.1 19028
4 EX-31.2 ortx-ex31_2.htm EX-31.2 19058
5 EX-32.1 ortx-ex32_1.htm EX-32.1 15653
  Complete submission text file 0000950170-22-014464.txt   13573158

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ortx-20220630.xsd EX-101.SCH 73595
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ortx-20220630_pre.xml EX-101.PRE 397061
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ortx-20220630_def.xml EX-101.DEF 223536
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ortx-20220630_cal.xml EX-101.CAL 70725
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ortx-20220630_lab.xml EX-101.LAB 541684
78 EXTRACTED XBRL INSTANCE DOCUMENT ortx-20220630_htm.xml XML 2472265
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 221134638
SIC: 2836 Biological Products, (No Diagnostic Substances)